Phase 1 Study of Randomized Clinical Trial Comparing Vitamin C Supplementation Plus Oral Hypoglycemic Drugs Versus Hypoglycemic Drugs Alone on Serum Selenium, Zinc, Copper and Malondialdehyde Levels in Type 2 Diabetes Mellitus and Its Microvascular Complications.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Glibenclamide (Primary) ; Ascorbic acid
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
Most Recent Events
- 18 Sep 2013 Biomarkers information updated
- 17 Sep 2013 Planned end date changed from 1 Apr 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 30 Jul 2012 Planned end date changed from 1 Apr 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.